LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

LLY

1,066.82

+2.48%↑

JNJ

234.57

+1.33%↑

ABBV

216.12

+0.45%↑

UNH

388.17

+1.5%↑

AZN

187.25

-1.32%↓

Home・Lista de Ações・Boston Scientific Corp.

Boston Scientific Corp.

Fechado

SetorSaúde

57.61 1.02

Comprar Vender

Visão Geral

Variação de preço das ações

24h

Atual

Mín

57.41

Máximo

57.67

Indicadores-chave
By Trading Economics
Rendimento	669M 1.3B
Vendas	-83M 5.2B
P/E Médio do Setor	23.398 49.701
EPS	0.8
Margem de lucro	25.774
Funcionários	59,000
EBITDA	116M 1.1B

Recomendações
By TipRanks
Recomendações	Compra Forte
Previsão para 12 meses	+51.66% upside

Dividendos
By Dow Jones
Próximos Ganhos	29 de jul. de 2026

Estatísticas de Mercado
By TradingEconomics
Capitalização de Mercado	-7.5B 83B
Abertura anterior	56.59
Fecho anterior	57.61

Sentimento de Notícias

By Acuity

26%

74%

59 / 345 Ranking em Healthcare

Boston Scientific Corp. Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

18 de mai. de 2026, 11:04 UTC

Aquisições, Fusões, Aquisições de Empresas

Boston Scientific Buys 34% Stake in MiRus for $1.5 Billion

22 de abr. de 2026, 11:22 UTC

Ganhos

Boston Scientific 1Q Net Grows Sharply, Company Cuts 2026 Adjusted EPS View

4 de fev. de 2026, 16:14 UTC

Ganhos

Grandes Movimentos do Mercado

Boston Scientific Plunges on Disappointing 1Q Outlook Despite 4Q Earnings Beat

4 de fev. de 2026, 12:13 UTC

Ganhos

Boston Scientific Sees More Growth after Earnings, Sales Rise

6 de mai. de 2026, 20:15 UTC

Ganhos

Penumbra Not Be Providing Fincl Guidance Due to Pending Acquisition by Boston Scientific >PEN

6 de mai. de 2026, 20:07 UTC

Ganhos

Penumbra 1Q Rev $374.8M >PEN

6 de mai. de 2026, 20:07 UTC

Ganhos

Penumbra 1Q EPS 82c >PEN

22 de abr. de 2026, 11:07 UTC

Ganhos

Boston Scientific 1Q Net Grows Sharply, Company Cuts 2026 Adj EPS View

22 de abr. de 2026, 10:32 UTC

Ganhos

Boston Scientific Now Sees 2026 Reported Sales Up 7%-8.5%, Organic Sales Up 6.5%-8% >BSX

22 de abr. de 2026, 10:31 UTC

Ganhos

Boston Scientific Sees 2Q Reported Sales Up 5.5%-7.5%, Organic Sales Up 5%-7% >BSX

22 de abr. de 2026, 10:30 UTC

Ganhos

Boston Scientific 1Q Organic Sales Up 9.4% >BSX

22 de abr. de 2026, 10:30 UTC

Ganhos

Boston Scientific 1Q Adj EPS 80c >BSX

22 de abr. de 2026, 10:30 UTC

Ganhos

Boston Scientific 1Q EPS 90c >BSX

22 de abr. de 2026, 10:30 UTC

Ganhos

Boston Scientific 1Q Sales $5.2B >BSX

22 de abr. de 2026, 10:30 UTC

Ganhos

Boston Scientific Sees 2Q Adj EPS 82c-Adj EPS 84c >BSX

22 de abr. de 2026, 10:30 UTC

Ganhos

Boston Scientific Sees FY Adj EPS $3.34-Adj EPS $3.41 >BSX

30 de mar. de 2026, 15:34 UTC

Conversa de Mercado

Boston Scientific Faces Some Slowing Growth Trends -- Market Talk

4 de fev. de 2026, 21:41 UTC

Ganhos

These Stocks Are Today's Movers: AMD, AbbVie, Boston Scientific, Eli Lilly, MP Materials, Super Micro, Palantir, and More -- Barrons.com

4 de fev. de 2026, 19:38 UTC

Ganhos

These Stocks Are Today's Movers: AMD, AbbVie, Boston Scientific, Eli Lilly, MP Materials, Super Micro, Palantir, and More -- Barrons.com

4 de fev. de 2026, 17:32 UTC

Ganhos

These Stocks Are Today's Movers: AMD, AbbVie, Eli Lilly, Boston Scientific, MP Materials, Super Micro, Silicon Labs, Uber, and More -- Barrons.com

4 de fev. de 2026, 15:30 UTC

Ganhos

Boston Scientific Earnings Beat Estimates. It's the Worst Stock in the S&P 500 Today. -- Barrons.com

4 de fev. de 2026, 15:29 UTC

Ganhos

These Stocks Are Today's Movers: AMD, Eli Lilly, AbbVie, Uber, Super Micro, Enphase, Boston Scientific, and More -- Barrons.com

4 de fev. de 2026, 14:06 UTC

Ganhos

Boston Scientific Profit, Sales Rise but Issues Soft Guidance -- Update

4 de fev. de 2026, 13:58 UTC

Ganhos

Boston Scientific Earnings Beat Expectations. Why the Stock Is Down Sharply. -- Barrons.com

4 de fev. de 2026, 13:12 UTC

Ganhos

Boston Scientific Earnings Beat Expectations. Why the Stock Is Down Sharply. -- Barrons.com

4 de fev. de 2026, 11:32 UTC

Ganhos

Boston Scientific Sees 2026 Sales Up 10.5%-11.5%, Organic Sales Up 10%-11% >BSX

4 de fev. de 2026, 11:31 UTC

Ganhos

Boston Scientific Sees 1Q Sales Up 10.5%-12%, Organic Sales Up 8.5%-10% >BSX

4 de fev. de 2026, 11:30 UTC

Ganhos

Boston Scientific 4Q Organic Sales Up 12.7% >BSX

4 de fev. de 2026, 11:30 UTC

Ganhos

Boston Scientific Sees 2026 Adj EPS $3.43-Adj EPS $3.49 >BSX

4 de fev. de 2026, 11:30 UTC

Ganhos

Boston Scientific Sees 1Q Adj EPS 78c-Adj EPS 80c >BSX

Comparação entre Pares

Variação de preço

Boston Scientific Corp. Previsão

Preço-alvo

By TipRanks

51.66% parte superior

Previsão para 12 meses

Média 87.63 USD 51.66%

Máximo 118 USD

Mínimo 68 USD

Com base em 27 analistas de Wall Street que oferecem metas de preço de 12 meses para Boston Scientific Corp. - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

27 ratings

Comprar

Manter

Vender

Com base em 27 analistas que deram avaliações de ações para Boston Scientific Corp. - Dist nos últimos 3 meses.

Sentimento

By Acuity

59 / 345 Ranking em Saúde

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

Sobre Boston Scientific Corp.

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, artificial urinary sphincter, laser system, fiber, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator system, proprietary programming software, radiofrequency generator, indirect decompression systems, practice optimization tools, and deep brain stimulation system. It also provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions; WATCHMAN FLX, a Left Atrial Appendage Closure Device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, the company offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose, treat and ease forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.